Current Assets Changement Date
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Adcock Ingram Holdings ZAR 4.61B 127.84M 2023-06
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Celltrion KRW 5.01T 1.61T 2023-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Incyte USD 4.65B 242.74M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Knight Therapeutics CAD 401.3M 15.93M 2023-09
Laboratorios Farma EUR 637.96M 14.89M 2023-06
Magenta Therapeutics USD 191.45M 112.82M 2023-09
Malin Corporation EUR 32.8M 142.3M 2023-06
Moderna USD 10.32B 474M 2023-12
Organigram Holdings CAD 180.4M 23.64M 2023-03
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pharma Mar EUR 260.97M 6.87M 2023-09
Qiagen NV USD 1.96B 349.04M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Sartorius EUR 2.02B 36M 2023-09
Sino Biopharmaceutical CNY 26.98B 1.04B 2023-06
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Zz Pientze Pharmaceu 14.13B 141.28M 2023-09



Moderna Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.